The cancer promoting effect of P16 is related to the activation of IL-6/JAK2/STAT3 pathway. Inhibition of P16 reduces the growth and metastatic potential of BC cells by inhibiting IL-6/JAK2/STAT3 signal transduction (122). This evidence concerns the gene JAK2 and breast cancer.